Fundraising Fox

Sonoma Biotherapeutics

South San Francisco, US · Founded 2019 · California corporation · 8 known investors

sonomabio.com ↗

Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases. The company uses proprietary platform technologies to create targeted and durable Treg cell therapies.

BiotechHealthtechMedical Devicesin /sonoma-biotherapeutics@sonomabio

Founders & leadership

FY
Fan YuDirector
MW
Maggie WilderotterDirector
TH
Toni HooverDirector
TR
Terry RosenDirector
RK
Richard KlausnerDirector
JB
Jeffrey BluestoneExecutive Officer, Director, Promoter

Investors · 8

8VCAustin · $500K – $50M
ARCH Venture PartnersChicago · $50K – $250M
Frazier Life SciencesPalo Alto
JDRF T1D FundBoston
LAVHong Kong · $5M – $15M
Lifeforce CapitalChevy Chase · $500K – $5M
Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M

Reported raises · per SEC filings

Form D private placements
▶$265MraisedAug 2021 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Fan YuDirector
  • Maggie WilderotterDirector
  • Toni HooverDirector
  • Terry RosenDirector
  • Richard KlausnerDirector
  • Jeffrey BluestoneExecutive Officer, Director, Promoter
Offering amount
$265M
Amount sold
$265M
First sale
Jul 2021
Incorporated
Corporation, California, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.